Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - IMMUCOR INCex99-1.htm


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

June 29, 2015

 

IMMUCOR, INC.

(Exact name of registrant as specified in its charter)

 

Georgia

0-14820

22-2408354

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

  

3130 Gateway Drive, Norcross, Georgia

30071

(Address of principal executive offices)

(Zip Code)

 

Registrant's telephone number, including area code: (770) 441-2051

 

Not Applicable

(Former name or former address,

if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 8.01 Other Events.

 

On June 29, 2015, Immucor, Inc. issued a press release announcing Jeffrey Binder as its new President, CEO and Chairman of the Board of Directors. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d)     Exhibits

 

99.1

Press Release, dated June 29, 2015.

 

 
-2- 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

 

 

IMMUCOR, INC.

   

 

   
   

 

   

Date: July 2, 2015

By:

/s/ Christopher Visick

   
   

Christopher Visick

Vice President, General Counsel and Secretary

 

 

 

 

 -3-